Multidrug-resistant tuberculosis around the world: What progress has been made?

European Respiratory Journal

Volumn 45, Issue 1, 2015, Pages 150-160

  Falzon, Dennis ^a   Mirzayev, Fuad ^a   Wares, Fraser ^a   Baena, Inés Garcia ^a   Zignol, Matteo ^a   Linh, Nguyen ^a   Weyer, Karin ^a   Jaramillo, Ernesto ^a   Floyd, Katherine ^a   Raviglione, Mario ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ARTICLE; DISEASE SURVEILLANCE; DRUG COST; GEOGRAPHIC DISTRIBUTION; HUMAN; INCOME; INFECTION CONTROL; LUNG TUBERCULOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION; BRAZIL; CHINA; COMMUNICABLE DISEASE CONTROL; HEALTH; INDIA; INFORMATION PROCESSING; POVERTY; RUSSIAN FEDERATION; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; BRAZIL; CHINA; COMMUNICABLE DISEASE CONTROL; DATA COLLECTION; GLOBAL HEALTH; HUMANS; INDIA; ISONIAZID; POVERTY; RIFAMPIN; RUSSIA; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH ORGANIZATION;

EID: 84920584733     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00101814     Document Type: Article

References (27)

1. Global tuberculosis report. 2013. WHO/HTM/TB/2013.11. Geneva, World Health Organization, 2013.
2. Floyd K, Hutubessy R, Kliiman K, et al. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia. Eur Respir J 2012; 40: 133-142.
3. Diel R, Vandeputte J, Vries G de, et al. Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation. Eur Respir J 2014; 43: 554-565.
4. Skrahina A, Hurevich H, Zalutskaya A, et al. Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors. Bull World Health Organ 2013; 91: 36-45.
5. Ulmasova D, Uzakova G, Tillyashayhov M, et al. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011. Euro Surveill 2013; 18: 20609.
6. Zignol M, van Gemert W, Falzon D, et al. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ 2012; 90: 111-119D.
7. Abubakar I, Zignol M, Falzon D, et al. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis 2013; 13: 529-539.
8. Ahuja SD, Ashkin D, Avendano M, et al. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med 2012; 9: e1001300
9. Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on MDR-TB outcomes. Eur Respir J 2013; 42: 156-168.
10. Migliori GB, Sotgiu G, Gandhi NR, et al. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. Eur Respir J 2013; 42: 169-179.
11. WHO Global Task Force outlines measures to combat XDR-TB worldwide. http://www. who.int/mediacentre/news/notes/2006/np29/en/Date last updated: October 17, 2006. Date last accessed: June 30, 2014.
12. Sixty-second World Health Assembly. Resolutions and decisions; annexes. WHA62.15 Prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. http://apps.who.int/gb/ebwha/pdf-files/WHA62-REC1/WHA62-REC1-en.pdf
13. The Global Planto Stop TB2011-2015: transforming the fight towards elimination of tuberculosis. WHO/HTM/STB/2010.2. Geneva, World Health Organization, 2010.
14. Laserson KF, Thorpe LE, Leimane V, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005; 9: 640-645.
15. Multidrug-resistant tuberculosis (MDR-TB) indicators. A minimum set of indicators for the programmatic management of MDR-TB in national tuberculosis control programmes. WHO/HTM/TB/2010.11. Geneva, World Health Organization, 2010.
16. Falzon D, Jaramillo E, Wares F, et al. Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data. Lancet Infect Dis 2013; 13: 690-697.
17. World Development Indicators. http://data.worldbank.org/data-catalog/world-development-indicators Date last updated: July 22, 2014. Date last accessed: May 30, 2014.
18. Wickham H. ggplot2: elegant graphics for data analysis. Springer, New York, 2009
19. R Project. R: a language and environment for statistical computing. Vienna, R Foundation for Statistical Computing, 2013.
20. Raviglione MC, Rieder HL, Styblo K, et al. Tuberculosis trends in eastern Europe and the former USSR. Tuber Lung Dis 1994; 75: 400-416.
21. Floyd K, Fitzpatrick C, Pantoja A, et al. Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002-11, and requirements to meet 2015 targets. The Lancet Global Health 2013; 1: e105-e115.
22. Raviglione M, Uplekar M, Vincent C, et al. Rebalancing the global battle against tuberculosis. The Lancet Global Health 2014; 2: e71-e72.
23. National Institute for Health and Clinical Excellence. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE clinical guideline 117. Manchester, National Institute for Health and Clinical Excellence, 2011.
24. The use of bedaquiline in the treatment of multidrug-resistant tuberculosis. Interim policy guidance. WHO/HTM/TB/2013.6. Geneva, World Health Organization, 2013.
25. European Medicines Agency. Human medicines: deltyba. http: //www.ema.europa.eu/docs/en-GB/document-library/EPAR-Summary-for-the-public/human/002552/WC500166235.pdf Date last updated: April 2014. Date last accessed: June 30, 2014.
26. With 75% of patients now enrolled in the STREAM MDR-TB trial, investigators meet to discuss progress and next steps. The Union. http://www.theunion.org/news-centre/news/with-75-of-patients-now-enrolled-in-the-streammdr-tb-trial-investigators-meet-to-discuss-progress-and-next-steps Date last updated: July 22, 2014. Date last accessed: August 26, 2014.
27. Sixty-seventh World Health Assembly. Resolution WHA67.1. Global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva, World Health Organization, 2014. Available from: http://apps. who.int/gb/ebwha/pdf-files/WHA67/A67-R1-en.pdf